Examination of the usefulness of the genetic test of Circulating tumor cells (CTCs) in patients with gastrointestinal cancer (Circle-1, Circle-2 Trial)
Phase 2
Recruiting
- Conditions
- clinical stage IV gastrointestinal cancer
- Registration Number
- JPRN-UMIN000014095
- Lead Sponsor
- ational Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1) Positive HIV antibody 2) Positive HBs antigen, HCV antibody 3) Positive TP antibody 4) Inadequate physical condition, as diagnosed by primary physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Circle-1: concordance rate in genetic mutational status in primary tumors and their corresponding CTCs. Circle-2: correlation between emergence of genetical mutations in CTCs and change in therapeutic effect during molecular targeted therapy.
- Secondary Outcome Measures
Name Time Method